Modelling optimal vaccination strategy for SARS-CoV-2 in the UK

Sam Moore, Edward M. Hill, Louise Dyson, Michael J. Tildesley, Matt J. Keeling
doi: https://doi.org/10.1101/2020.09.22.20194183

Article usage

Article usage: September 2020 to December 2024

AbstractFullPdf
Sep 202014020375
Oct 20203920260
Nov 20204980604
Dec 2020371501704
Jan 2021356001698
Feb 2021180921492
Mar 2021125560467
Apr 202160738237
May 202148128146
Jun 20213102194
Jul 2021176853
Aug 20211731567
Sep 2021240952
Oct 20211651451
Nov 20211481245
Dec 202110117828
Jan 202212717332
Feb 20229411145
Mar 20227211533
Apr 20228316446
May 2022741242
Jun 202241212
Jul 202257523
Aug 202275716
Sep 2022801620
Oct 20224412110
Nov 2022338915
Dec 202260519
Jan 202356723
Feb 202348812
Mar 20233125
Apr 2023105335
May 202317216
Jun 202316612
Jul 202320311
Aug 202327159
Sep 202328813
Oct 202325217
Nov 2023441912
Dec 202323612
Jan 20243169
Feb 202426917
Mar 202429918
Apr 202419928
May 202418610
Jun 2024241522
Jul 202424814
Aug 202441922
Sep 202432721
Oct 2024321719
Nov 202433824
Dec 20241128
Back to top
Posted September 24, 2020.
Download PDF
Data/Code
Email
Modelling optimal vaccination strategy for SARS-CoV-2 in the UK
Sam Moore, Edward M. Hill, Louise Dyson, Michael J. Tildesley, Matt J. Keeling
medRxiv 2020.09.22.20194183; doi: https://doi.org/10.1101/2020.09.22.20194183
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area